V. Jackson

Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.

P. Loria, D. Hepworth, S. Bhattacharya, 2014, ACS medicinal chemistry letters.

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor

A. Mathiowetz, P. Loria, A. Kalgutkar, 2022, Journal of medicinal chemistry.

A small-molecule oral agonist of the human glucagon-like peptide-1 receptor

Margaret S. Landis, A. Mathiowetz, P. Loria, 2020, bioRxiv.